Shlomo Yanai
CIK 1562645 · last filed 2026-05-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.37M
Companies
9
Total Filings
40
Lifetime Open-Market Net
-$2.15M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMw | Director | 10,120 | — | — | $0 | 6 | 2026-05-08 |
| AMRX | Director | 320,804 | $16.20 | $5.20M | $0 | 10 | 2026-05-08 |
| CAMBREX CORP (CBM) Delisted | Director | 29,473 | — | — | -$2.15M | 8 | 2019-12-05 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Director | 54,348 | — | — | $0 | 2 | 2019-06-24 |
| DAR | Director | 3,010 | $56.99 | $171.5K | $0 | 2 | 2019-05-09 |
| Exela Technologies, Inc. (XELAW) Delisted | Director | 20,500 | — | — | $0 | 1 | 2017-07-14 |
| PRGO | Director | 443 | $10.99 | $4.9K | $0 | 3 | 2016-05-23 |
| Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Director | 742 | — | — | $0 | 3 | 2016-04-18 |
| PLX | Director | — | $2.09 | — | $0 | 1 | 2014-07-24 |
Recent Filings · Page 4 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-06 | PRGO | Mixed | +443 | $42.4K | EDGAR |
| 2016-04-22 | CAMBREX CORP (CBM) Delisted | Grant (A) | +1,330 | $0 | EDGAR |
| 2016-04-18 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Exer (M) | +742 | $0 | EDGAR |
| 2016-02-23 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-11-06 | PRGO | Grant (A) | — | $0 | EDGAR |
| 2015-05-01 | CAMBREX CORP (CBM) Delisted | Grant (A) | +1,271 | $0 | EDGAR |
| 2015-04-17 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-07-24 | PLX | Grant (A) | — | $0 | EDGAR |
| 2013-04-29 | CAMBREX CORP (CBM) Delisted | Mixed | +3,956 | $0 | EDGAR |
| 2012-11-29 | CAMBREX CORP (CBM) Delisted | Grant (A) | +1,695 | $0 | EDGAR |
Showing 31–40 of 40
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.